Recursion Pharmaceuticals Inc vs Valero Energy Corporation — how do they compare? Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B), while Valero Energy Corporation trades at $314.02 (market cap $93.03B). The key difference: Valero Energy Corporation is far larger — about 60.8× Recursion Pharmaceuticals Inc's market cap, and Valero Energy Corporation pays a 1.53% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | VLO | |
|---|---|---|
Market Cap | $1.53B | $93.03B |
Sector | Health | Energy |
52-Week High | $6.79 | $313.31 |
52-Week Low | $2.84 | $131.77 |
Enterprise Value | $946.50M | $98.79B |
Dividend Yield | — | 1.53% |
Trailing returns across standard periods
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →